The vaccination coverage in dispensaries on Mayotte Island is lacking for natives and migrants alike - 28/04/21
, O. LesensBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 3 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | This concerns the first prospective study on dispensary vaccination coverage in the northern part of Mayotte from June to July 2019. |
• | We have shown that vaccination coverage and its traceability are both generally insufficient, whatever the patient's age or origin. |
• | Vaccination schedule updating and follow-up can be improved with effort, especially considering the lack of opposition to vaccination. |
Abstract |
Objective |
Assessing the vaccination coverage rate in Mayotte dispensaries.
Patients and methods |
Prospective study in three dispensaries from June to July 2019.
Results |
Of the 162 patients included, 78% (126/162) were natives of the island and 19% (30/162) were from the Comoros Islands. Twenty-three percent (37/162) were up-to-date on their mandatory vaccinations, 45% (73/162) were not and 32% (52/162) had unknown vaccination status. There was no difference in relation to their origin. Some vaccinations were strictly followed (MMR, Hepatitis B…) others were not (HiB, meningitides…). The vaccination coverage rate and its traceability are altogether lacking whatever the age or origin of patients. Efforts must be made in order to increase the vaccination coverage rate among people who, from our experience, do not oppose vaccination in any way.
Le texte complet de cet article est disponible en PDF.Keywords : Mayotte, Vaccination
Plan
Vol 51 - N° 3
P. 290-292 - mai 2021 Retour au numéro
Article précédent
- Influenza vaccination coverage at community pharmacies: Positioning, needs, expectations and involvement of community pharmacists in the Franche-Comté region
- M. Kroemer, A.L. Clairet, K. Kabiche, A. Bendjama, X. Bertrand, S. Limat, V. Nerich
- Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration
- A. Poncelet, L. Ruelle, D. Konopnicki, V.Y. Miendje Deyi, N. Dauby
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?